Similar Articles
1171 Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
1172 Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection
1173 Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma
1174 Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome
1175 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
1176 Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma
1177 Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment
1178 Hepatitis B viral load affects prognosis of hepatocellular carcinoma
1179 Characterization of monocarboxylate transporter activity in hepatocellular carcinoma
1180 Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA